BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ortiz Zacarías NV, van Veldhoven JPD, Portner L, van Spronsen E, Ullo S, Veenhuizen M, van der Velden WJC, Zweemer AJM, Kreekel RM, Oenema K, Lenselink EB, Heitman LH, IJzerman AP. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2. J Med Chem 2018;61:9146-61. [PMID: 30256641 DOI: 10.1021/acs.jmedchem.8b00605] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Huber ME, Toy L, Schmidt MF, Weikert D, Schiedel M. Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric Binding Site of GPCRs. Chemistry A European J 2022. [DOI: 10.1002/chem.202202565] [Reference Citation Analysis]
2 Nguyen NT, Dai VV, Tri NN, Van Meervelt L, Trung NT, Dehaen W. Experimental and theoretical studies on the synthesis of 1,4,5-trisubstituted pyrrolidine-2,3-diones. Beilstein J Org Chem 2022;18:1140-53. [DOI: 10.3762/bjoc.18.118] [Reference Citation Analysis]
3 Toy L, Huber ME, Schmidt MF, Weikert D, Schiedel M. Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2. ACS Chem Biol 2022. [PMID: 35838163 DOI: 10.1021/acschembio.2c00263] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Liang L, Liu H, Xing G, Deng C, Hua Y, Gu R, Lu T, Chen Y, Zhang Y. Accurate calculation of absolute free energy of binding for SHP2 allosteric inhibitors using free energy perturbation. Phys Chem Chem Phys 2022;24:9904-20. [PMID: 35416820 DOI: 10.1039/d2cp00405d] [Reference Citation Analysis]
5 Billen M, Schols D, Verwilst P. Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists. Chem Commun (Camb) 2022;58:4132-48. [PMID: 35274633 DOI: 10.1039/d1cc07080k] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Nguyen NT, Dai VV, Mechler A, Hoa NT, Vo QV. Synthesis and evaluation of the antioxidant activity of 3-pyrroline-2-ones: experimental and theoretical insights. RSC Adv 2022;12:24579-88. [DOI: 10.1039/d2ra04640g] [Reference Citation Analysis]
7 Asif M, Alghamdi S. An Overview on Biological Importance of Pyrrolone and Pyrrolidinone Derivatives as Promising Scaffolds. Russ J Org Chem 2021;57:1700-1718. [DOI: 10.1134/s1070428021100201] [Reference Citation Analysis]
8 Ortiz Zacarías NV, Bemelmans MP, Handel TM, de Visser KE, Heitman LH. Anticancer opportunities at every stage of chemokine function. Trends Pharmacol Sci 2021;42:912-28. [PMID: 34521537 DOI: 10.1016/j.tips.2021.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
9 Ortiz Zacarías NV, Chahal KK, Šimková T, van der Horst C, Zheng Y, Inoue A, Theunissen E, Mallee L, van der Es D, Louvel J, IJzerman AP, Handel TM, Kufareva I, Heitman LH. Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2. J Med Chem 2021;64:2608-21. [PMID: 33600174 DOI: 10.1021/acs.jmedchem.0c01137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Miao M, De Clercq E, Li G. Clinical significance of chemokine receptor antagonists. Expert Opin Drug Metab Toxicol 2020;16:11-30. [PMID: 31903790 DOI: 10.1080/17425255.2020.1711884] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 27.5] [Reference Citation Analysis]
11 Ortiz Zacarías NV, van Veldhoven JPD, den Hollander LS, Dogan B, Openy J, Hsiao YY, Lenselink EB, Heitman LH, IJzerman AP. Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5. J Med Chem 2019;62:11035-53. [PMID: 31742400 DOI: 10.1021/acs.jmedchem.9b00742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
12 Kenakin T. G-Protein/Receptor inhibitors as blockers of receptor signaling. J Theor Biol 2019;480:23-33. [PMID: 31356763 DOI: 10.1016/j.jtbi.2019.07.014] [Reference Citation Analysis]
13 Lu S, He X, Ni D, Zhang J. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design. J Med Chem 2019;62:6405-21. [DOI: 10.1021/acs.jmedchem.8b01749] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 32.3] [Reference Citation Analysis]